BioCatalyst

Brepocitinib PO QD — catalyst calendar

1 verified catalyst event(s) referencing Brepocitinib PO QD, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-11
in 3mo
ESTIMATED
 READOUT
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uvei
Phase 3 · Uveitis, Posterior, Uveitis, Intermediate
 Priovant Therapeutics, Inc. Brepocitinib PO QD ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.